Auris Medical Inc. (NASDAQ: EARS) stock rises during current market. Why is it so?
Auris Medical Inc. (NASDAQ: EARS) stock gains by 25.08% in the current market trading. Auris Medical is a clinical-stage pharmaceutical organization focused on developing treatments for unmet medical needs in neurotology, rhinology, asthma, and CNS disorders. EARS is working on intranasal betahistine for the cure of vertigo (AM-125, in Phase 2) and the reduction of […]